Micro Life Sciences Private Limited and its existing investor Warburg Pincus, on the proposed fund raise of US 200 million from Abu Dhabi Investment Authority.

AZB & Partners advised Micro Life Sciences Private Limited (‘Meril’), one of India’s leading medical devices companies, and its existing investor Warburg Pincus, on the proposed fund raise of US 200 million from Abu Dhabi Investment Authority (‘ADIA’). The investment values Meril at an enterprise value of USD 6.6 billion.

Our deal team comprised of our Senior Partner Vaidhyanadhan Iyer, Partner Jeet Chaudhuri, Senior Associates Shivani Shenoy and Vyoma Mehta, and Associate Janhavi Rajkumar. They were supported by Associates Akanksha Khandelwal, Shloka Jain, Pavit Kaur, Rishad A. Mehta and Tarini Mehtani on the due diligence; Partner Nandan Pendsey, Senior Associate Rhea Ghanshani and Associate Labdhi Golechha on the IP aspects; Partner Vikram Shroff and Associate Yashashwini Santuka on the employment law aspects; Senior Associates Veeral Vakharia, Rohan Puskur and Associate Divya Pani on the real estate aspects; Senior Partner Bharat Budholia, Senior Associate Varun Thakur and Associate Ashna Mahajan on the competition law aspects.

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.